These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study.
    Author: Aliyev ZN, Aliyev NA.
    Journal: Alcohol Alcohol; 2008; 43(4):456-9. PubMed ID: 18495806.
    Abstract:
    AIMS: The aim of this study was to compare the efficacy and safety of valproate (Depakine-Chrono) versus placebo for the treatment of acute alcohol hallucinosis. METHODS: 10 days' randomized, double-blind, parallel study was conducted; 40 patients with an ICD-10 diagnosis of acute alcohol hallucinosis were randomized to valproate (Depakine-Chrono) 3000 mg/day (n = 20) or placebo (n = 20). The primary efficacy measure was the Clinical Global Improvement (CGI) and the Positive and Negative Syndrome Scale (PANSS), subscale for hallucinosis. RESULTS: Valproate-treated patients demonstrated a greater improvement than placebo-treated patients in CGI (P < 0.001) and PANSS subscale for verbal hallucinosis (P < 0.001). CONCLUSION: Valproate is effective in the treatment of acute hallucinosis and is generally well tolerated.
    [Abstract] [Full Text] [Related] [New Search]